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Key Clinical Message 
 
We shall discuss a patient who underwent a tricuspid valve-in-valve implantation for a failing 
bioprosthetic valve replacement. The procedure was complicated by detachment of the valve 
deployment apparatus which was removed in its entirety, using percutaneous extraction 
techniques. We believe this was the first ever case to report such a complication. 
 
Introduction 
 
The management of severe tricuspid regurgitation (TR) in the absence of other cardiac 
abnormalities can be difficult, with a high risk of surgical complications.[1] If surgery is carried 
out, bioprosthetic valve replacements (BVR) are preferred but, following the operation, 
recurrent TR may be seen within a few years. [2] Furthermore, surgical intervention for failing 
BVR’s is associated with a high risk of morbidity and mortality and this has led to the 
development of a percutaneous approach to treat such patients, using a tricuspid valve-in-
valve (TVIV) implant.[3] This technique involves placing a transcatheter aortic valve prosthesis 
within the BVR, in an off-label indication. A multi-centre registry has recently demonstrated 
this technique is both technically and clinically successful, with the majority of patients 
reporting improvement in their functional class.[4] We shall present a case of a patient that 
underwent a TVIV which was complicated by device detachment that was successfully treated 
using a percutaneous femoral extraction technique. 
 
Case Report 
 
An 87-year-old patient was referred for percutaneous TVIV implantation after complaining of 
breathlessness and peripheral oedema. Three years previously she had received a BVR for 
severe TR. Her functional status deteriorated and she became increasingly breathlessness 
with signs of right heart failure. Echocardiography demonstrated the presence of a severe 
trans-valvular leak through her BVR with preserved biventricular systolic function. Her case 
was discussed at a multi-disciplinary meeting and it was thought that re-doing tricuspid valve 
(TV) surgery would be too high risk and it was decided that, instead, a TVIV implant should be 
performed. Initially the procedure was performed using a femoral approach but due to 
difficulty achieving stable positions across the TV, the access site was changed to the right 
internal jugular vein (RIJV). A 26mm Edwards SAPIEN 3 heart valve was successfully deployed 
across the BVR and ballooned into place with an excellent result (Figure 1). 
 
We were unable to remove the balloon delivery system as it had become entangled with the 
left ventricular pacing lead. The cause was likely to have been the Edwards SAPIEN 3 heart 
valve having partially occluded the coronary sinus, resulting in entanglement of the left 
ventricular lead and balloon delivery system. We applied continuous traction via the RIJV, 
causing displacement of the left ventricular lead but the balloon delivery system remained 
wedged in place. We therefore cut the apparatus at the skin leaving it within the superior 
vena cava and right atrium (Figure 2 and 3). The options to remove the retained device were 
discussed, including surgical removal, and it was agreed to attempt percutaneous snaring of 
the device. Initially we tried to snare the device from the RIJV with a Goose-neck® snare 
(Amplatz) but this was unsuccessful, so we proceeded to extract via the right femoral route. 
Given the length of the retained balloon delivery system, we selected a 30mm Goose-neck® 
snare (Amplatz). Using fluoroscopic guidance, we were able to snare the apparatus and by 
applying gentle traction in different directions, this came away from the left ventricular lead. 
We were then able to remove it via the femoral vein in its entirety (Figure 4). Bleeding was 
controlled with a ProGlide® device and manual pressure. The extracted device and balloon 
were approximately 15cm in length (Figure 5). An echocardiogram, which was carried out the 
following day, demonstrated the TVIV was well seated with normal forward flow velocities 
and no significant TR. The patient made a good recovery after the procedure and was 
discharged home. Given the complications that had arisen, we decided to re-position the 
displaced left ventricular lead several weeks later. Unfortunately, we were unable to pass the 
stylet to the tip of the lead and, therefore decided to abandon the old lead, and placed a new 
left ventricular lead in the high lateral vein. The patient made an uneventful recovery. She 
was reviewed in clinic several months following the intervention. Her symptoms had 
markedly improved, with less dyspnoea and peripheral oedema.  
 
Discussion 
 
The mainstay of treatment for severe TR is medical therapy, although in selected cases, 
surgical intervention can be beneficial.[5] However, recurrence of TR following surgical 
intervention has been seen in 20% of patients at the five year follow-up appointment[1]. 
Given the high surgical risk associated with re-doing surgery, TVIV implantation for a 
dysfunctional BVR is becoming an increasingly appealing option. Transcatheter aortic 
implants have already been successfully placed in the aortic and mitral valve positions with 
good outcomes. As we become more experienced with the use of TVIV, this will improve 
procedural and patient outcomes. 
 
This case describes the successful management of a complication arising from a TVIV 
procedure. The retained balloon delivery system was successfully removed percutaneously 
using snaring techniques and equipment, usually employed for percutaneous 
pacemaker/defibrillator lead extraction. This meant we could avoid open surgical extraction, 
which would have been associated with a significant risk of morbidity and mortality.[6] To our 
knowledge, there are no reported cases involving intravascular detachment of the balloon 
delivery apparatus used to implant a TVIV. In this case it was likely to have been caused by 
the pacing leads that prevented removal of the device from the RIJV. When we encountered 
this situation, we attempted a step-wise extraction technique as advocated in the current HRS 
consensus document.[6] Superior extraction using a Goose-neck® snare was not possible, 
thus we changed to a femoral route to enable us to use more traction and a larger snare. The 
balloon delivery apparatus was removed via this route and the patient made a good recovery.  
 
Conclusion 
 
This case highlights the benefit to using percutaneous extraction techniques using femoral 
snaring.  Given the rise in percutaneous valve implantations, this technique may have 
increasing importance in the future. As these cases can be complex, it emphasises the 
importance of experience in this setting when a significant complication occurs. To our 
knowledge this is the first case report of a TVIV device detachment, treated by percutaneous 
extraction, which meant we could avoid surgical intervention.  
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